imatinib

The medicine is used in adults and children for the treatment of, among others, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome (or chronic eosinophilic leukemia), and dermatofibrosarcoma protuberans.

Form: capsules, hard

ATC: L01XE01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used in the treatment of adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), certain myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), as well as in dermatofibrosarcoma protuberans (DFSP).

Form: capsules, hard

ATC: L01XE01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used to treat adults and children with acute lymphoblastic leukemia (Philadelphia chromosome-positive), certain myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome or chronic eosinophilic leukemia, as well as for the treatment of dermatofibrosarcoma protuberans.

Form: capsules, hard

ATC: L01XE01

Manufacturer: Nobilus Ent

The medicine is used in adults and children for the treatment of acute lymphoblastic leukemia (with the Philadelphia chromosome), certain myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, and dermatofibrosarcoma protuberans.

Form: capsules, hard

ATC: L01XE01

Manufacturer: Nobilus Ent

The medicine is used in adults and children for the treatment of, among others, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome (or chronic eosinophilic leukemia), and dermatofibrosarcoma protuberans.

Form: capsules, hard

ATC: L01XE01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicine is used to treat adults and children with chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, certain myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, and dermatofibrosarcoma protuberans.

Form: capsules, hard

ATC: L01XE01

Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.

The medicinal product is used in the treatment of adults and children with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also indicated in adults for the treatment of myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Lek d.d., Pe Proizvodnja Landava LEK Pharmaceuticals d.d. Novartis Pharma GmbH Salutas Pharma GmbH

The medicine is used in adults and children for the treatment of, among others, chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Lek d.d., PE Proizvodnja Lendava LEK Pharmaceuticals d.d. Novartis Pharma GmbH Salutas Pharma GmbH

The medicine is used to treat adults and children with certain types of cancer, such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Pharmadox Healthcare Ltd., Remedica Ltd

The medicine is used to treat adults and children with chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), certain myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Pharmadox Healthcare Ltd., Remedica Ltd

The medicine is used in adults, children, and adolescents for the treatment of, among others, chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), and dermatofibrosarcoma protuberans (DFSP).

Form: capsules, hard

ATC: L01EA01

Manufacturer: Nobilus Ent

The medicine is used in adults, children, and adolescents for the treatment of, among others, chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), as well as dermatofibrosarcoma protuberans (DFSP).

Form: capsules, hard

ATC: L01EA01

Manufacturer: Nobilus Ent

The medicine is used for the treatment of adults and children in the case of chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL), gastrointestinal stromal tumors (GIST), and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH

The medicine is used in the treatment of adults and children with chronic myeloid leukemia, Philadelphia chromosome-positive acute lymphoblastic leukemia, myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, and chronic eosinophilic leukemia. It is also used in the treatment of gastrointestinal stromal tumors (GIST) and dermatofibrosarcoma protuberans (DFSP).

Form: tablets, film-coated

ATC: L01EA01

Manufacturer: Krka, d.d., Novo mesto Krka-Farma d.o.o. TAD Pharma GmbH